Dear Friends and Supporters of STM,
On behalf of my fellow members of the Governing Council, it is my pleasure to invite you to join us in sunny Florida and be part of the 32nd Annual Meeting of the Society for Thermal Medicine. We will meet April 14 – 17, 2015 in Orlando for what is shaping up to be another excellent line-up of respected speakers addressing important topics in the field of thermal medicine. In addition to our most popular and in-demand topics, new for this year we will be featuring a symposium on analytical methods and techniques relevant for thermal biology and medicine.
As we are also gathering in the #1 family tourist destination in the world, our theme
for this year is ‘The Wonderful World of Thermal Medicine’. We will be sure to leave
time for attendees to explore the area with their families. You may want to arrive a
day or two early and extend your stay by a couple days to allow enough time to visit the most famous theme parks in the world.
This event continues to grow because of the free exchange of research data and ideas. Colleagues and corporate partners continue to give us positive feedback on the line-up of quality speakers and timely topics. We look forward to seeing you at STM 2015! If you, or your company, have additional ideas not listed here for sponsorship and involvement, please do not hesitate to contact us to discuss. Sponsors are encouraged to consider submitting an abstract for presentation.
Sincerely,
Erik N.K. Cressman, PhD, MD, FSIR
Program Chair, President-Elect, Society for Thermal Medicine
Email: ecressman@mdanderson.org
Rob Griffin, PhD
President, Society for Thermal Medicine
Email: rjgriffin@uams.edu
Annual Meeting Program Committee
Nicole Levi-Polyachenko, Wake Forest University
Rivka Colen, MD Anderson Cancer Center
Muneeb Ahmed, Beth Israel Deaconess Hospital
Jason Stafford, MD Anderson Cancer Center
John Pearce, University of Texas Austin
Dieter Haemmerich, Medical University of South Carolina
Robert J. Griffin, University of Arkansas for Medical Sciences
Betsy Repasky, Roswell Park Cancer Institute
Bruno Odisio, MD Anderson Cancer Center
Jennifer Yu, Cleveland Clinic
John Baust, Binghamton University
Chris Brace, University of Wisconsin
2015 STM Meeting
2015 Program Chair
Keynote Speakers
Prof. Yost received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida. He has risen through the ranks at UF to Professor and Head of the Analytical Chemistry Division. His research has involved 100 graduate students funded by over $20 million in research grants, and has led to the publication of over 160 papers and 16 patents. Over $30 billion worth of instruments have been sold based on these patents. Also contributing to these research efforts have been a number of collaborators at UF and around the world, visiting scientists, plus undergraduate and high school researchers. Current research interests center on instrumental developments, fundamental studies, and analytical applications of tandem mass spectrometry and ion mobility, including imaging mass spectrometry and FAIMS. Prof. Yost recently completed a two-year term as member of the Florida Board of Governors (Regents) and Chair of the Advisory Council of Faculty Senates of Florida. He is past Chair of the UF Faculty Senate and has served on the UF Board of Trustees. He has served as the Treasurer and Secretary of the American Society for Mass Spectrometry, and has served on the editorial boards of The Journal of the American Society for Mass Spectrometry and The International Journal of Mass Spectrometry. Prof. Yost’s research was recognized with the 1993 ASMS Award for Distinguished Contribution in Mass Spectrometry.
Dr. Vander Heiden is the Eisen and Chang Career Development professor and associate professor of biology at MIT and an instructor in medicine at both Harvard Medical School and the Dana-Farber Cancer Institute. He has been a Member of the Scientific Advisory Board at Agios Pharmaceuticals, Inc. since 2008. He received the Burroughs Wellcome Fund Career Award for Medical Scientists in 2009. Dr. Vander Heiden earned his B.S. in Biological Chemistry, M.D. and Ph.D. from the University of Chicago. Learn more about the Vander Heiden lab and their efforts to better understand cancer cell metabolism and how small molecules might be used to activate enzymes and restore the normal state of cells - http://youtu.be/nOteIR2veoI.
Alexander (Sasha) V. Kabanov, Ph.D., Dr.Sc.
Alexander “Sasha” Kabanov, PhD, DrSci, is the Mescal Swaim Ferguson Distinguished Professor and director of the Center for Nanotechnology in Drug Delivery at the UNC Eshelman School of Pharmacy and codirector of the Carolina Institute for Nanomedicine at the University of North Carolina at Chapel Hill. Prior to joining UNC-Chapel Hill in July 2012, Kabanov served for nearly eighteen years at the University of Nebraska Medical Center where he was the Parke-Davis Professor of Pharmaceutical Sciences and director of the Center for Drug Delivery and Nanomedicine, which he founded in 2004. Kabanov received his PhD in chemical kinetics and catalysis in 1987 at Moscow State University, USSR.
Kabanov has conducted pioneering research on polymeric micelles, DNA/polycation complexes, block ionomer complexes and nanogels for delivery of small drugs, and nucleic acids and proteins that have influenced considerably current ideas and approaches in drug delivery and nanomedicine. His work led to the first-in-man polymeric micelle drug (SP1049C) to treat cancer, which successfully completed Phase II clinical trial and is under further evaluation. He cofounded Supratek Pharma, Inc. (Montreal, Canada), which develops therapeutics for cancer, and Neuro10-9, Inc. (Omaha, Nebraska, and Chapel Hill, North Carolina), which focuses on diseases of the central nervous system.
Kabanov has published more than 240 scientific papers and has more than 100 patents worldwide. His work has been cited over 16,700 times (Hirsch index 71). His cumulative research support in academia has been more than $50 million. His inventions have attracted nearly $60 million in private, foundation, and company-sponsored R&D funding in industry. He founded the ongoing Nanomedicine and Drug Delivery Symposium series in 2003 and cochaired the Gordon Research Conference on Drug Carriers in Medicine and Biology in 2006.
Kabanov received the Lenin Komsomol Prize in 1988, an NSF Career Award in 1995, the University of Nebraska ORCA Award in 2007, and the University of Nebraska Medical Center Scientist Laureate in 2009, among other distinctions. He is also the recipient of a Russian Megagrant (2010). In 2013, he was elected as a member of Academia Europaea.
Kabanov was director of the Nebraska Center for Nanomedicine, an NIH Center of Biomedical Research Excellence, from 2008 to 2012 and is a director of the Moscow State University Laboratory of Chemical Design of Bionanomaterials, which he founded at in 2010 with Megagrant support.
2015 Meeting Sponsors
